Perspective Therapeutics (CATX) Work In Process (2011 - 2023)

Perspective Therapeutics has disclosed Work In Process across 11 years of filings, most recently posting $616000.0 for Q1 2023.

• Work In Process for Q1 2023 came in at $616000.0, up 73.52% year-over-year; the trailing twelve-month figure through Mar 2023 was $616000.0 (up 73.52% YoY), and the FY2022 annual result was $636000.0, changed N/A from the prior year.
• Work In Process came in at $616000.0 for Q1 2023 at Perspective Therapeutics, down from $636000.0 in the prior quarter.
• In the past five years, Work In Process ranged from a high of $636000.0 in Q4 2022 to a low of $114000.0 in Q1 2019.
• The 5-year median for Work In Process is $240000.0 (2020), against an average of $306000.0.
• Across the five-year window, Work In Process retreated 25.49% in 2019 and surged 129.1% in 2022, its largest moves.
• Perspective Therapeutics' Work In Process stood at $166000.0 in 2019, then climbed by 26.51% to $210000.0 in 2020, then soared by 37.14% to $288000.0 in 2021, then jumped by 120.83% to $636000.0 in 2022, then declined by 3.14% to $616000.0 in 2023.
• The last three Work In Process figures came in at $616000.0 (Q1 2023), $636000.0 (Q4 2022), and $614000.0 (Q3 2022), per Business Quant data.